scispace - formally typeset
Open AccessJournal ArticleDOI

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Reads0
Chats0
TLDR
It is demonstrated that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses, and can serve as potential biomarkers for the detection of various cancers and other diseases.
Abstract
Dysregulated expression of microRNAs (miRNAs) in various tissues has been associated with a variety of diseases, including cancers. Here we demonstrate that miRNAs are present in the serum and plasma of humans and other animals such as mice, rats, bovine fetuses, calves, and horses. The levels of miRNAs in serum are stable, reproducible, and consistent among individuals of the same species. Employing Solexa, we sequenced all serum miRNAs of healthy Chinese subjects and found over 100 and 91 serum miRNAs in male and female subjects, respectively. We also identified specific expression patterns of serum miRNAs for lung cancer, colorectal cancer, and diabetes, providing evidence that serum miRNAs contain fingerprints for various diseases. Two non-small cell lung cancer-specific serum miRNAs obtained by Solexa were further validated in an independent trial of 75 healthy donors and 152 cancer patients, using quantitative reverse transcription polymerase chain reaction assays. Through these analyses, we conclude that serum miRNAs can serve as potential biomarkers for the detection of various cancers and other diseases.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Genomic and proteomic biomarkers for cancer: A multitude of opportunities

TL;DR: Novel genomic, proteomic and metabolomic technologies are being used to discover and validate tumor biomarkers individually and in panels, with the expectation that panels of biomarker analytes rather than single markers will be needed to have sufficient sensitivity and specificity for the presymptomatic detection of cancer.
Journal ArticleDOI

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease

TL;DR: Results from this exploratory study indicate that downregulated levels of specific circulating serum miRNAs are associated with PD and suggest their potential use as noninvasive biomarkers for PD.
Journal ArticleDOI

MicroRNAs: tools for cancer diagnostics

TL;DR: It is demonstrated that cancer cells have different miRNA profiles compared with normal cells, thus underscoring the tremendous diagnostic and therapeutic potential of miRNAs in cancer.
Journal ArticleDOI

Aberrant expression of serum miRNAs in schizophrenia

TL;DR: The findings suggested that the serum miRNAs have strong potential to reflect schizophrenia disease status and the risperidone may not be an effective drug in regulating serum miR-346 level of schizophrenia.
References
More filters
Journal Article

MicroRNA signatures in human cancers

TL;DR: The causes of the widespread differential expression of miRNA genes in malignant compared with normal cells can be explained by the location of these genes in cancer-associated genomic regions, by epigenetic mechanisms and by alterations in the miRNA processing machinery as discussed by the authors.
Journal Article

Oncomirs : microRNAs with a role in cancer

TL;DR: I MicroRNAs (miRNAs) are an abundant class of small non-protein-coding RNAs that function as negative gene regulators as discussed by the authors, and have been shown to repress the expression of important cancer-related genes and might prove useful in the diagnosis and treatment of cancer.
Journal ArticleDOI

Real-time quantification of microRNAs by stem–loop RT–PCR

TL;DR: A novel microRNA quantification method has been developed using stem–loop RT followed by TaqMan PCR analysis, which enables fast, accurate and sensitive miRNA expression profiling and can identify and monitor potential biomarkers specific to tissues or diseases.
Related Papers (5)